Total Payments
$23,015
2024 Payments
$3,455
Companies
54
Transactions
1,051
Medicare Patients
5,527
Medicare Billing
$4.2M
Payment Breakdown by Category
Food & Beverage$18,098 (78.6%)
Research$4,709 (20.5%)
Education$208.22 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,098 | 1,044 | 78.6% |
| Unspecified | $4,709 | 3 | 20.5% |
| Education | $208.22 | 4 | 0.9% |
Payments by Type
General
$18,306
1,048 transactions
Research
$4,709
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $4,709 | 3 | $0 (2020) |
| Amgen Inc. | $2,857 | 166 | $0 (2024) |
| ABBVIE INC. | $1,736 | 117 | $0 (2024) |
| Janssen Biotech, Inc. | $1,734 | 121 | $0 (2024) |
| UCB, Inc. | $1,701 | 70 | $0 (2024) |
| PFIZER INC. | $1,594 | 134 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,099 | 68 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,090 | 50 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $744.54 | 40 | $0 (2024) |
| Genentech USA, Inc. | $694.44 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,455 | 168 | UCB, Inc. ($462.99) |
| 2023 | $3,488 | 185 | Janssen Biotech, Inc. ($525.20) |
| 2022 | $2,971 | 155 | Janssen Biotech, Inc. ($572.95) |
| 2021 | $1,395 | 81 | Amgen Inc. ($219.73) |
| 2020 | $1,158 | 58 | Amgen Inc. ($339.11) |
| 2019 | $3,580 | 125 | Eli Lilly and Company ($1,844) |
| 2018 | $4,682 | 128 | Eli Lilly and Company ($2,809) |
| 2017 | $2,286 | 151 | Amgen Inc. ($403.59) |
All Payment Transactions
1,051 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/23/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Immunology | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.03 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Bone Health | ||||||
| 12/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $37.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: Immunology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $23.08 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $4.21 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $3.71 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Zimmer Biomet Holdings, Inc. | Gel-One Cross-linked Hyaluronate (Device) | Food and Beverage | In-kind items and services | $43.83 | General |
| Category: Knees | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/22/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $44.24 | General |
| Category: Immunology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $38.85 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $7.93 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $24.08 | General |
| 11/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Bone Health | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3 MULTICENTER STUDY TO EVALUATE THE LONG TERM SAFETY AND EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | Eli Lilly and Company | $4,709 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,183 | 29,995 | $2.0M | $663,146 |
| 2022 | 21 | 1,296 | 55,145 | $2.3M | $808,171 |
| 2021 | 24 | 1,413 | 52,555 | $2.9M | $1.0M |
| 2020 | 26 | 1,635 | 85,423 | $4.3M | $1.7M |
Total Patients
5,527
Total Services
223,118
Medicare Billing
$4.2M
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 20 | 4,400 | $352,000 | $148,365 | 42.1% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 42 | 5,510 | $743,850 | $144,198 | 19.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 83 | 7,080 | $212,400 | $130,712 | 61.5% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 28 | 10,844 | $325,320 | $114,084 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 446 | $66,900 | $42,963 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 235 | 448 | $56,000 | $32,109 | 57.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 107 | 235 | $117,500 | $24,492 | 20.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 64 | 113 | $19,750 | $7,020 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $11,250 | $6,487 | 57.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $6,930 | $2,668 | 38.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 87 | 235 | $29,375 | $2,631 | 9.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 47 | 103 | $20,600 | $2,399 | 11.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 33 | $3,630 | $1,444 | 39.8% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 72 | 288 | $8,640 | $1,274 | 14.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 19 | 20 | $8,000 | $1,107 | 13.8% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 18 | 90 | $10,800 | $583.05 | 5.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 20 | 36 | $2,880 | $477.72 | 16.6% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 17 | 31 | $930.00 | $132.70 | 14.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 43 | 5,720 | $772,200 | $165,102 | 21.4% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 18 | 4,850 | $388,000 | $163,537 | 42.1% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2022 | 12 | 25,780 | $257,800 | $119,574 | 46.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 79 | 6,960 | $208,800 | $119,058 | 57.0% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 20 | 9,600 | $288,000 | $113,201 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 419 | $62,850 | $40,443 | 64.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 238 | 391 | $48,875 | $28,085 | 57.5% |
About Bruce Hoffman
Bruce Hoffman is a Rheumatology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760431548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bruce Hoffman has received a total of $23,015 in payments from pharmaceutical and medical device companies, with $3,455 received in 2024. These payments were reported across 1,051 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($18,098).
As a Medicare-enrolled provider, Hoffman has provided services to 5,527 Medicare beneficiaries, totaling 223,118 services with total Medicare billing of $4.2M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Philadelphia, PA
- Active Since 05/09/2006
- Last Updated 07/01/2010
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760431548
Products in Payments
- Enbrel (Biological) $1,692
- Cimzia (Drug) $1,569
- XELJANZ (Drug) $1,415
- TREMFYA (Drug) $1,243
- SAPHNELO (Biological) $1,067
- RINVOQ (Biological) $1,038
- COSENTYX (Biological) $813.24
- EVENITY (Biological) $744.83
- ORENCIA (Biological) $744.54
- Rituxan (Biological) $530.12
- PURIFIED CORTROPHIN GEL (Drug) $515.86
- ACTHAR (Biological) $462.41
- BENLYSTA (Biological) $426.47
- Humira (Biological) $353.01
- KEVZARA (Biological) $336.48
- TALTZ (Drug) $328.63
- COSENTYX (Drug) $268.66
- REMICADE (Biological) $261.74
- KEVZARA (Drug) $243.06
- SKYRIZI (Biological) $214.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Philadelphia
Dr. Alan Epstein, M.d, M.D
Rheumatology — Payments: $1.7M
Rheumatology $1.7M
Alexis Ogdie-Beatty, Md, MD
Rheumatology — Payments: $543,413
Rheumatology $543,413
Lawrence Brent, Md, MD
Rheumatology — Payments: $26,698
Rheumatology $26,698
Ethan Craig, Md, MD
Rheumatology — Payments: $20,704
Rheumatology $20,704
Monica Luchi, Md, MD
Rheumatology — Payments: $20,434
Rheumatology $20,434
Dr. Jill Johnson, M.d, M.D
Rheumatology — Payments: $15,757
Rheumatology $15,757